Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Gut Microbial Catabolites of Tryptophan Are Ligands and Agonists of the Aryl Hydrocarbon Receptor: A Detailed Characterization

B. Vyhlídalová, K. Krasulová, P. Pečinková, A. Marcalíková, R. Vrzal, L. Zemánková, J. Vančo, Z. Trávníček, J. Vondráček, M. Karasová, S. Mani, Z. Dvořák

. 2020 ; 21 (7) : . [pub] 20200409

Language English Country Switzerland

Document type Journal Article

Grant support
20-00449S Grantová Agentura České Republiky
PrF-2020-006 Univerzita Palackého v Olomouci
RVO 68081707 Akademie Věd České Republiky
P30CA013330 NIH HHS - United States
P30DK020541 NIH HHS - United States
CA127231 NIH HHS - United States
CA161879 NIH HHS - United States
PR160167 U.S. Department of Defense
R43DK105694 U.S. Department of Defense
P30DK041296 U.S. Department of Defense
362520 Crohn's and Colitis Foundation of America

We examined the effects of gut microbial catabolites of tryptophan on the aryl hydrocarbon receptor (AhR). Using a reporter gene assay, we show that all studied catabolites are low-potency agonists of human AhR. The efficacy of catabolites differed substantially, comprising agonists with no or low (i3-propionate, i3-acetate, i3-lactate, i3-aldehyde), medium (i3-ethanol, i3-acrylate, skatole, tryptamine), and high (indole, i3-acetamide, i3-pyruvate) efficacies. We displayed ligand-selective antagonist activities by i3-pyruvate, i3-aldehyde, indole, skatole, and tryptamine. Ligand binding assay identified low affinity (skatole, i3-pyruvate, and i3-acetamide) and very low affinity (i3-acrylate, i3-ethanol, indole) ligands of the murine AhR. Indole, skatole, tryptamine, i3-pyruvate, i3-acrylate, and i3-acetamide induced CYP1A1 mRNA in intestinal LS180 and HT-29 cells, but not in the AhR-knockout HT-29 variant. We observed a similar CYP1A1 induction pattern in primary human hepatocytes. The most AhR-active catabolites (indole, skatole, tryptamine, i3-pyruvate, i3-acrylate, i3-acetamide) elicited nuclear translocation of the AhR, followed by a formation of AhR-ARNT heterodimer and enhanced binding of the AhR to the CYP1A1 gene promoter. Collectively, we comprehensively characterized the interactions of gut microbial tryptophan catabolites with the AhR, which may expand the current understanding of their potential roles in intestinal health and disease.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21012711
003      
CZ-PrNML
005      
20210507102527.0
007      
ta
008      
210420s2020 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/ijms21072614 $2 doi
035    __
$a (PubMed)32283770
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Vyhlídalová, Barbora $u Department of Cell Biology and Genetics, Faculty of Science, Palacky University, Slechtitelu 27, 783 71 Olomouc, Czech Republic
245    10
$a Gut Microbial Catabolites of Tryptophan Are Ligands and Agonists of the Aryl Hydrocarbon Receptor: A Detailed Characterization / $c B. Vyhlídalová, K. Krasulová, P. Pečinková, A. Marcalíková, R. Vrzal, L. Zemánková, J. Vančo, Z. Trávníček, J. Vondráček, M. Karasová, S. Mani, Z. Dvořák
520    9_
$a We examined the effects of gut microbial catabolites of tryptophan on the aryl hydrocarbon receptor (AhR). Using a reporter gene assay, we show that all studied catabolites are low-potency agonists of human AhR. The efficacy of catabolites differed substantially, comprising agonists with no or low (i3-propionate, i3-acetate, i3-lactate, i3-aldehyde), medium (i3-ethanol, i3-acrylate, skatole, tryptamine), and high (indole, i3-acetamide, i3-pyruvate) efficacies. We displayed ligand-selective antagonist activities by i3-pyruvate, i3-aldehyde, indole, skatole, and tryptamine. Ligand binding assay identified low affinity (skatole, i3-pyruvate, and i3-acetamide) and very low affinity (i3-acrylate, i3-ethanol, indole) ligands of the murine AhR. Indole, skatole, tryptamine, i3-pyruvate, i3-acrylate, and i3-acetamide induced CYP1A1 mRNA in intestinal LS180 and HT-29 cells, but not in the AhR-knockout HT-29 variant. We observed a similar CYP1A1 induction pattern in primary human hepatocytes. The most AhR-active catabolites (indole, skatole, tryptamine, i3-pyruvate, i3-acrylate, i3-acetamide) elicited nuclear translocation of the AhR, followed by a formation of AhR-ARNT heterodimer and enhanced binding of the AhR to the CYP1A1 gene promoter. Collectively, we comprehensively characterized the interactions of gut microbial tryptophan catabolites with the AhR, which may expand the current understanding of their potential roles in intestinal health and disease.
650    _2
$a zvířata $7 D000818
650    _2
$a transkripční faktory bHLH $x agonisté $x metabolismus $7 D051792
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a cytochrom P-450 CYP1A1 $x genetika $7 D019363
650    12
$a střevní mikroflóra $x účinky léků $7 D000069196
650    _2
$a exprese genu $7 D015870
650    _2
$a reportérové geny $7 D017930
650    _2
$a lidé $7 D006801
650    _2
$a indoly $7 D007211
650    _2
$a ligandy $7 D008024
650    _2
$a metabolické sítě a dráhy $7 D053858
650    _2
$a myši $7 D051379
650    _2
$a promotorové oblasti (genetika) $7 D011401
650    _2
$a vazba proteinů $7 D011485
650    _2
$a multimerizace proteinu $7 D055503
650    _2
$a receptory aromatických uhlovodíků $x agonisté $x metabolismus $7 D018336
650    _2
$a tryptofan $x metabolismus $7 D014364
655    _2
$a časopisecké články $7 D016428
700    1_
$a Krasulová, Kristýna $u Department of Cell Biology and Genetics, Faculty of Science, Palacky University, Slechtitelu 27, 783 71 Olomouc, Czech Republic
700    1_
$a Pečinková, Petra $u Department of Cell Biology and Genetics, Faculty of Science, Palacky University, Slechtitelu 27, 783 71 Olomouc, Czech Republic
700    1_
$a Marcalíková, Adéla $u Department of Cell Biology and Genetics, Faculty of Science, Palacky University, Slechtitelu 27, 783 71 Olomouc, Czech Republic
700    1_
$a Vrzal, Radim $u Department of Cell Biology and Genetics, Faculty of Science, Palacky University, Slechtitelu 27, 783 71 Olomouc, Czech Republic
700    1_
$a Zemánková, Lenka $u Department of Cell Biology and Genetics, Faculty of Science, Palacky University, Slechtitelu 27, 783 71 Olomouc, Czech Republic
700    1_
$a Vančo, Jan $u Division of Biologically Active Complexes and Molecular Magnets, Regional Centre of Advanced Technologies and Materials, Faculty of Science, Palacký University, Šlechtitelů 27, 783 71 Olomouc, Czech Republic
700    1_
$a Trávníček, Zdeněk $u Division of Biologically Active Complexes and Molecular Magnets, Regional Centre of Advanced Technologies and Materials, Faculty of Science, Palacký University, Šlechtitelů 27, 783 71 Olomouc, Czech Republic
700    1_
$a Vondráček, Jan $u Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Královopolská 135, 61265 Brno, Czech Republic
700    1_
$a Karasová, Martina $u Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Královopolská 135, 61265 Brno, Czech Republic
700    1_
$a Mani, Sridhar $u Department of Genetics and Department of Medicine, Albert Einstein College of Medicine, Bronx, NY 10461, USA
700    1_
$a Dvořák, Zdeněk $u Department of Cell Biology and Genetics, Faculty of Science, Palacky University, Slechtitelu 27, 783 71 Olomouc, Czech Republic
773    0_
$w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 21, č. 7 (2020)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32283770 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210420 $b ABA008
991    __
$a 20210507102527 $b ABA008
999    __
$a ok $b bmc $g 1650970 $s 1133090
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 21 $c 7 $e 20200409 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
GRA    __
$a 20-00449S $p Grantová Agentura České Republiky
GRA    __
$a PrF-2020-006 $p Univerzita Palackého v Olomouci
GRA    __
$a RVO 68081707 $p Akademie Věd České Republiky
GRA    __
$a P30CA013330 $p NIH HHS $2 United States
GRA    __
$a P30DK020541 $p NIH HHS $2 United States
GRA    __
$a CA127231 $p NIH HHS $2 United States
GRA    __
$a CA161879 $p NIH HHS $2 United States
GRA    __
$a PR160167 $p U.S. Department of Defense
GRA    __
$a R43DK105694 $p U.S. Department of Defense
GRA    __
$a P30DK041296 $p U.S. Department of Defense
GRA    __
$a 362520 $p Crohn's and Colitis Foundation of America
LZP    __
$a Pubmed-20210420

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...